RJFSA
DNLI icon

Raymond James Financial Services Advisors’s Denali Therapeutics DNLI Stock Holding History

Raymond James Financial Services Advisors’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,252
Closed -$215K – 3343
2021
Q3 		$215K Hold
4,252
– – ﹤0.01% 2929
2021
Q2 		$334K Sell
4,252
-80
-2% -$4.95K ﹤0.01% 2646
2021
Q1 		$247K Sell
4,332
-400
-8% -$26.8K ﹤0.01% 2757
2020
Q4 		$396K Buy
+4,732
New +$286K ﹤0.01% 2285
2019
Q2 		– Sell
-9,588
Closed -$223K – 2858
2019
Q1 		$223K Sell
9,588
-475
-5% -$9.94K ﹤0.01% 2430
2018
Q4 		$208K Sell
10,063
-10,390
-51% -$188K ﹤0.01% 2237
2018
Q3 		$445K Buy
20,453
+2,200
+12% +$36.4K ﹤0.01% 2005
2018
Q2 		$278K Buy
+18,253
New +$344K ﹤0.01% 2288

Other funds holding DNLI

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $29.7B AUM 13.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return